Nefopam Medisol (Nefopam Hydrochloride)

Nefopam Hydrochloride, the active ingredient in Nefopam Medisol, is a non‑opioid analgesic presented as an injectable solution for intramuscular and intravenous use. It is indicated for the management of moderate acute pain and post‑operative pain in adult patients. GNH USA supplies Nefopam Medisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nefopam is a non‑opioid analgesic used to manage pain through central mechanisms.

- Moderate acute pain: provides analgesia for short‑term severe pain following injury or illness. - Post‑operative pain: reduces pain intensity after surgical procedures. - Procedural pain: alleviates discomfort associated with diagnostic or therapeutic procedures.

Nefopam may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Sweating: increased perspiration. - Dizziness: transient light‑headedness. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Seizures: rare occurrence of convulsions. - Severe hypotension: sudden drop in blood pressure. - Allergic reactions: rash, angioedema, or anaphylaxis.

Before prescribing Nefopam Medisol, clinicians should consider several safety factors.

- Assess cardiovascular status: monitor blood pressure and heart rate before administration. - Review CNS disorders: avoid in patients with a history of seizures. - Evaluate renal/hepatic function: adjust use if significant impairment is present. - Avoid concomitant MAO inhibitors: risk of hypertensive crisis. - Use with caution in elderly: increased sensitivity to side effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Nefopam can interact with several medication classes; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension. - Antidepressants (SSRIs, SNRIs, TCAs): may increase serotonergic effects. - Anticonvulsants (e.g., carbamazepine): potential reduction of analgesic efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood pressure‑lowering effect. - Anesthetics: may enhance central nervous system depression. - Diuretics: possible electrolyte disturbances.